2014
DOI: 10.1007/s10620-014-3159-6
|View full text |Cite
|
Sign up to set email alerts
|

MicroRNA-194 Inhibits the Epithelial–Mesenchymal Transition in Gastric Cancer Cells by Targeting FoxM1

Abstract: Our study clearly demonstrates that miR-194 inhibits the acquisition of the EMT phenotype in gastric cancer cells by downregulating FoxM1, thereby inhibiting cell migration and invasion during cancer progression.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
42
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(44 citation statements)
references
References 20 publications
2
42
0
Order By: Relevance
“…Importantly, comparison between our current serum based study and a previous study undertaken in our laboratory which evaluated tissue based miRNAs associated with development of esophageal adenocarcinoma identified an overlap of 4 miRNAs, miR-194-5p, miR30a-5p, miR-15b-5p and miR-17-5p [20]. miR-194-5p and miR-30a-5p have been shown to be associated with epithelial-mesenchymal transition, which is one of the hallmarks of more aggressive cancers [21,22]. Recent studies have demonstrated an important role for miR-15b-5p (and miR-16-5p that lies in the same genomic cluster), in regulating apoptosis, cell cycle and DNA repair pathways [23], and highlighted miR-15b-5p as a potential target for anti-cancer therapies [24].…”
Section: Discussionsupporting
confidence: 57%
“…Importantly, comparison between our current serum based study and a previous study undertaken in our laboratory which evaluated tissue based miRNAs associated with development of esophageal adenocarcinoma identified an overlap of 4 miRNAs, miR-194-5p, miR30a-5p, miR-15b-5p and miR-17-5p [20]. miR-194-5p and miR-30a-5p have been shown to be associated with epithelial-mesenchymal transition, which is one of the hallmarks of more aggressive cancers [21,22]. Recent studies have demonstrated an important role for miR-15b-5p (and miR-16-5p that lies in the same genomic cluster), in regulating apoptosis, cell cycle and DNA repair pathways [23], and highlighted miR-15b-5p as a potential target for anti-cancer therapies [24].…”
Section: Discussionsupporting
confidence: 57%
“…As for whether H19 [38,39]. More specifically, miR-194 could suppress invasion of gastric cancer and liver cancer cells, and miR-194's interfering with the EMT process of tumor cells also strengthened this effect [21,40]. Another investigation found that miR-194 might motivate formation of colonic neoplasms by targeting AKT2, and this effect was mediated by PI3K/Akt/mTOR signaling pathway [41].…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, the effect exerted by miR-194 on FoxM1 was suggested to be involved in the EMT process of neoplasms [21], and several microarray assays revealed that FoxM1 was highly expressed within > 20 solid neoplasms, including hepatocellular carcinoma, pancreatic adenocarcinoma, mastocarcinoma, ovarian cancer, lung cancer and CRC [43][44][45][46][47]. Besides, FoxM1 was over-expressed within actively-proliferating tumor cells, and it functioned to facilitate cell multiplication mainly by regulating cell cycle-specific genes [48].…”
Section: Discussionmentioning
confidence: 99%
“…For example, Han et al demonstrated that overexpression of miR-194 significantly repressed the proliferation, migration, and invasion of osteosarcoma cells in vitro, as well as tumour growth and pulmonary metastasis in vivo by targeting cadherin-2 (CDH2) and insulin-like growth factor 1 receptor (IGF-1R) [12]. In addition, it has been reported that miR-194 inhibited the EMT of EC cells [14] and gastric cancer cells [18]. MiR-194 has been identified as a prognostic marker of clear cell renal cell carcinoma (ccRCC) [19], myelodysplastic syndromes (MDS) [20], and HCC [15].…”
Section: Discussionmentioning
confidence: 99%